Not applicableUnknownNCT02852850What this trial is testingIn Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative ColitisWho this might be right forUlcerative Colitis Shandong University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07419880What this trial is testingRe-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast CancerWho this might be right forTriple -Negative Breast Cancer Fudan University 46
Not applicableStudy completedNCT00267826What this trial is testingImmunopharmacological Effects of Rituximab in Atopic DermatitisWho this might be right forDermatitis, Atopic University of Bern 6
Testing effectiveness (Phase 2)Study completedNCT00048555What this trial is testingSafety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma Biogen 90
Large-scale testing (Phase 3)Study completedNCT00049517What this trial is testingCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML LeukemiaWho this might be right forLeukemia Eastern Cooperative Oncology Group 657
Early research (Phase 1)Study completedNCT01969643What this trial is testingA Safety Study of SGN-LIV1A in Breast Cancer PatientsWho this might be right forHER2 Positive Breast NeoplasmsHormone Receptor Positive Breast NeoplasmsTriple Negative Breast Neoplasms+1 more Seagen Inc. 290
Early research (Phase 1)Study completedNCT02216890What this trial is testingSafety Study of SGN-CD70A in Cancer PatientsWho this might be right forRenal Cell CarcinomaMantle-Cell LymphomaDiffuse, Large B-Cell, Lymphoma+1 more Seagen Inc. 38
Not applicableLooking for participantsNCT05664035What this trial is testingFrequency of SPAD in Adult PatientsWho this might be right forSpecific Antibody DeficiencyPredominantly Antibody Deficiencies University Hospital, Lille 99
Large-scale testing (Phase 3)Study completedNCT00000117What this trial is testingIntravenous Immunoglobulin Therapy in Optic NeuritisWho this might be right forOptic Neuritis National Eye Institute (NEI)
Testing effectiveness (Phase 2)UnknownNCT05138146What this trial is testingClinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue SarcomaWho this might be right forSarcoma, Soft Tissue Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07318883What this trial is testingA Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung CancerWho this might be right forSquamous NSCLC Shanghai Henlius Biotech 720
Testing effectiveness (Phase 2)Looking for participantsNCT04495296What this trial is testingA Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Cancer Suzhou Transcenta Therapeutics Co., Ltd. 320
Early research (Phase 1)Study completedNCT02350673What this trial is testingIntravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid TumorsWho this might be right forSolid Tumors Hoffmann-La Roche 70
Testing effectiveness (Phase 2)Study completedNCT00217594What this trial is testingA Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndromes National Heart, Lung, and Blood Institute (NHLBI) 40
Not applicableNot Yet RecruitingNCT07544953What this trial is testingAmyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD PathologyWho this might be right forParkinson Disease Yonsei University 60
Post-approval studies (Phase 4)Study completedNCT06637072What this trial is testingAssess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SCWho this might be right forChronic Inflammatory Demyelinating Polyneuropathy argenx 23
Early research (Phase 1)Study completedNCT01204996What this trial is testingThe Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid TumorsWho this might be right forCancer Centocor, Inc. 53
Post-approval studies (Phase 4)Active Not RecruitingNCT06285370What this trial is testingEvaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic TherapyWho this might be right forCutaneous T-Cell Lymphoma Kyowa Kirin China Pharmaceutical Co., Ltd. 23
Early research (Phase 1)Study completedNCT01008566What this trial is testingCixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more National Cancer Institute (NCI) 21
Not applicableApproved For MarketingNCT04100694What this trial is testingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorWho this might be right forNRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more Merus B.V.